Evidence map›Paper›PMID 36417212›Full record

ArticleEpidemiologia (Basel, Switzerland)2021

Epidemiological Analysis of COVID-19 Cases in Native Amazonian Communities from Peru.

Cecilia Pajuelo-Reyes, Hugo J Valencia, Carla C Montenegro, Eduardo Quezada, Lizandro Gonzales, Norma Cruz, Carlos Canelo, Carla Ordinola, Jorge L Maicelo Quintana, Juan R Tejedo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Epidemiologia (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Cecilia Pajuelo-ReyesInstituto de Enfermedades Tropicales (IET), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Chachapoyas 01001, Peru.ORCID 0000-0002-7712-4453
Hugo J ValenciaInstituto de Enfermedades Tropicales (IET), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Chachapoyas 01001, Peru.
Carla C MontenegroInstituto de Enfermedades Tropicales (IET), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Chachapoyas 01001, Peru.
Eduardo QuezadaDirección Regional de Salud (DIRESA), Chachapoyas 01001, Peru.
Lizandro GonzalesDirección Regional de Salud (DIRESA), Chachapoyas 01001, Peru.
Norma CruzDirección Regional de Salud (DIRESA), Chachapoyas 01001, Peru.
Carlos CaneloGobierno Regional de Amazonas (GOREA), Chachapoyas 01001, Peru.
Carla OrdinolaInstituto de Enfermedades Tropicales (IET), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Chachapoyas 01001, Peru.
Jorge L Maicelo QuintanaInstituto de Investigación para el Desarrollo Sustentable de Ceja de Selva (INDES-CES), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Chachapoyas 01001, Peru.
Juan R TejedoInstituto de Enfermedades Tropicales (IET), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Chachapoyas 01001, Peru.ORCID 0000-0002-8434-7516
Rafael Tapia-LimonchiInstituto de Enfermedades Tropicales (IET), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Chachapoyas 01001, Peru.ORCID 0000-0001-7483-1729
Stella M ChenetInstituto de Enfermedades Tropicales (IET), Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Chachapoyas 01001, Peru.ORCID 0000-0002-5305-0664
National University Toribio Rodríguez de Mendoza · PEDirección Regional de Salud del Callao · PEUniversidad de Los Andes, Chile · CL

Funding

Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica 09-2019-FONDECYT-BM-INC.INV
6 · The paper itself

Abstract

Despite early control measures, SARS-CoV-2 reached all regions of Peru during the first wave of the pandemic, including native communities of the Peruvian Amazon. Here, we aimed to describe the epidemiological situation of COVID-19 in the Amazonas region of Peru using an open database of 11,124 COVID-19 cases reported from 19 March to 29 July 2020, including 3278 cases from native communities. A high-incidence area in northern Amazonas (Condorcanqui) reported a cumulative incidence of 63.84/1000 inhabitants with a much lower death rate (0.95%) than the national average. Our results showed at least eight significant factors for mortality, and the Native Amazonian ethnicity as a protective factor. Molecular confirmatory tests are necessary to better explain the high incidence of antibody response reported in these communities.

Indexed as

COVID-19epidemiologyhazard rationative communitiesPeruRDTstransmission chain

Identifiers

PMID36417212
PMCPMC9620947
OpenAlexW3205136975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.